Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales

التفاصيل البيبلوغرافية
العنوان: Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales
المؤلفون: Becky Pennington, C. Righetti, M. Lebmeier, N.J. Brereton
المصدر: Value in Health. 16(7):A578-A579
بيانات النشر: Elsevier BV, 2013.
سنة النشر: 2013
مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, business.industry, Rheumatoid arthritis, First line, Health Policy, medicine, Public Health, Environmental and Occupational Health, medicine.disease, business, Intensive care medicine
تدمد: 1098-3015
DOI: 10.1016/j.jval.2013.08.1576
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cbadad93e8fa49ec6b8e7e86c191519
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....8cbadad93e8fa49ec6b8e7e86c191519
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2013.08.1576